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In the previous issue of Critical Care, Haugk and colleagues [1] report a retrospective analysis of 13 years of therapeutic hypothermia (TH) cases, suggesting a surprising association between faster rates of cooling and less favorable neurological outcomes. Th eir data generate some fascinating hypotheses and opportunities for future research but clinicians would be ill-advised, based on both our understanding of pathophysiology and the growing body of published evidence, to use this study as justifi cation to relax eff orts to achieve target temperatures as quickly as possible.
Precisely how TH improves neurological outcome after cardiac arrest is not known, but the mechanism is probably multi-factorial. TH is thought to minimize the release and the eff ect of free radicals, excitatory neurotransmitters and protease cascades during reperfusion of ischemic brain tissue, and may decrease vasoconstriction and intravascular thrombosis leading to potential ongoing micro-ischemia [2] . TH may also amplify the release of neuroprotective proteins [3] . For any of these proposed mechanisms, initiation of TH as soon as possible following resuscitation should be preferable.
Animal models that have been used to study TH have supported early, rapid cooling [4, 5] . In fact, one of the greatest challenges of advancing animal research into the clinical realm has been the diffi culty in matching the rapid induction methods achieved in the laboratory in human subjects, with the hopes of observing similar therapeutic benefi ts. Although no prospective, randomized clinical trials have assessed the eff ect of time to target temperature on neurological outcome, there are noteworthy signals from existing human trials that support a benefi t to rapid cooling. Wolff and colleagues [6] analyzed patients rapidly cooled using an endo vascular device and showed that the time to target temperature was an independent predictor for a good outcome (odds ratio 0.69 (0.51 to 0.98)). Although underpowered, recent clinical trials of rapid cooling devices have shown trends toward survival benefi t [7] and improvement in patient outcomes compared to historical controls [8] .
Retrospective data reviews are fraught with potential problems, and are best used to generate hypotheses for future rigorous prospective evaluation. Despite Haugk and colleagues' eff orts to control for confounders statistically, their study does not demonstrate whether it is the rate of cooling or diff erences in other important variables infl uencing neurological outcome following TH. At most, this study suggests a statistical association, but there is not suffi cient biological plausibility to suggest a causal relationship. As the authors point out, their fi ndings might well imply that greater neurological injury is predicted by more rapid achievement of cooling during TH, rather than rapid cooling itself being inherently harmful. Th ere is a plausible argument to be made that patients with more severe anoxic injury may be easier to cool to target temperature quickly because of damage of the thermoregulatory areas of the brain. In Haugk and colleagues' population, the starting temperatures in patients with poor neurological outcomes were half a degree lower before TH was started, suggesting that
Abstract
The rapid institution of therapeutic hypothermia after cardiac arrest has become an accepted practice. In the previous issue of Critical Care, Haugk and colleagues present a retrospective analysis of 13 years of experience with therapeutic hypothermia at their center that suggests an association between rate of cooling and less favorable neurological outcomes. The association most likely refl ects easier cooling in patients more severely brain injured by their initial cardiac arrest, and should not lead clinicians to abandon or slow their eff orts to achieve postresuscitative cooling.
these patients were already showing some degree of impaired thermoregulation.
Researchers addressing the timing of TH induction face a diffi cult challenge -to separate the issues of time from return-of-spontaneous-circulation to target temperature, rate of cooling, and impaired thermoregulation. Th is will no doubt take place in a population that will vary in time to presentation for cooling and patient factors that aff ect the rate of cooling. Th ere have been tremendous advancements in the methods available to cool patients quickly; cooling rates were originally in the area of 0.32°C per hour but we can now achieve rates more than ten-times faster [8] and are in a position to question how best to cool our patients.
It is time for researchers to ask and answer these challenging questions. Until then, clinicians should continue in their eff orts to cool patients post-cardiac arrest as quickly as possible.
Abbreviations TH, therapeutic hypothermia.
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